Skip to main navigation Skip to search Skip to main content

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus

  • Marc Evans
  • , Richard A. Anderson
  • , John Graham
  • , Gethin R. Ellis
  • , Keith Morris
  • , Stephen Davies
  • , Simon K. Jackson
  • , Malcolm J. Lewis
  • , Michael P. Frenneaux
  • , Alan Rees

Research output: Contribution to journal › Article › peer-review

215 Citations (Scopus)

Abstract

Exaggerated postprandial lipemia (PPL) is a factor in atherogenesis, involving endothelial dysfunction and enhanced oxidative stress. We examined the effect of ciprofibrate therapy on these parameters in type 2 diabetes mellitus.
Original languageEnglish
Pages (from-to)1773-1779
Number of pages7
JournalCirculation
Volume101
Issue number15
DOIs
Publication statusPublished - 18 Apr 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult
  • Analysis of Variance
  • Area Under Curve
  • Cholesterol, HDL
  • Clofibric Acid
  • Diabetes Mellitus, Type 2
  • Double-Blind Method
  • Endothelium, Vascular
  • Female
  • Fibric Acids
  • Humans
  • Hypolipidemic Agents
  • Lipids
  • Male
  • Middle Aged
  • Oxidative Stress
  • Postprandial Period
  • Triglycerides

Access to Document

Cite this